A third coronavirus vaccine may be made available in India soon. Serum Institute of India (SII) CEO Adar Poonawala has given important information about this. Poonawalla said in a tweet that, the Serum Institute has also demonstrated excellent efficacy results in partnership with Novavax for the COVID-19 vaccine. He further added that he has applied to start testing this vaccine in India and is expected to launch the vaccine – Covovax by June 2021. According to Novovax, the Covid-19 vaccine ‘Novovax’ has shown 89.3% efficacy in its Phase 3 clinical trial in the United Kingdom. A study assessed the efficacy